文献速递心律失常血脂与心血管预防

心房颤动患者缺血性卒中风险评分在不同肾功能水平中的验证

Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function.
PubMed 文献 · Eur Heart J · 2021-01-01

本研究基于SCREAM队列中36 004例新诊断房颤患者,在正常、轻度和晚期慢性肾脏病三个肾功能分层中验证六种缺血性卒中风险评分的预测性能。中位随访1.9年,8.5%患者发生缺血性卒中;区分度随肾功能下降而降低,但改良CHADS2评分在各肾功能分层中表现良好且校准合理。

要点

  • 多数风险评分在慢性肾脏病临床相关阶段预测性能不佳,增加错分及过度或治疗不足风险。
  • 改良CHADS2评分在各肾功能分层中区分度和校准均良好,应优先用于房颤患者风险估计。
  • 风险评分的区分度依赖eGFR,正常肾功能时中位c-statistic为0.75,轻度和晚期CKD降至0.68。

核心结论

  • 在慢性肾脏病最临床相关的阶段,多数缺血性卒中风险评分的预测性能较差,增加错分及过度或治疗不足风险。
  • 改良CHADS2评分在所有肾功能分层中表现良好且一致,应优先用于房颤患者风险估计。

研究设计与样本

  • 基于SCREAM(Stockholm CREAtinine Measurements)医疗利用队列,纳入36 004例新诊断房颤患者。
  • 评估AFI、CHADS2、改良CHADS2、CHA2DS2-VASc、ATRIA和GARFIELD-AF六种风险评分在三个肾功能分层的预测性能,通过区分度和校准评估。

主要发现

  • 中位随访1.9年,3069例(8.5%)患者发生缺血性卒中。
  • 区分度依赖eGFR:正常肾功能中位c-statistic为0.75(范围0.68-0.78),轻度CKD降至0.68(0.58-0.73),晚期CKD为0.68(0.55-0.74)。
  • 校准基本合理且大体独立于eGFR。
  • 改良CHADS2评分在各肾功能分层中区分度良好:c-statistic分别为0.78(95%CI 0.77-0.79)、0.73(95%CI 0.71-0.74)和0.74(95%CI 0.69-0.79),校准亦良好。

关键数值与推荐

  • 肾功能分层:正常肾功能eGFR >60 mL/min/1.73 m2,轻度CKD eGFR 30-60 mL/min/1.73 m2,晚期CKD eGFR <30 mL/min/1.73 m2。
  • 改良CHADS2评分在各肾功能分层的c-statistic分别为0.78(95%CI 0.77-0.79)、0.73(95%CI 0.71-0.74)和0.74(95%CI 0.69-0.79)。

临床怎么用

  • 房颤患者进行缺血性卒中风险估计时,应优先考虑改良CHADS2评分,尤其在合并慢性肾脏病时。
  • 对慢性肾脏病患者使用其他风险评分需警惕区分度下降导致的错分风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The increasing prevalence of ischaemic stroke (IS) can partly be explained by the likewise growing number of patients with chronic kidney disease (CKD). Risk scores have been developed to identify high-risk patients, allowing for personalized anticoagulation therapy. However, predictive performance in CKD is unclear. The aim of this study is to validate six commonly used risk scores for IS in atrial fibrillation (AF) patients across the spectrum of kidney function. METHODS AND RESULTS: Overall, 36 004 subjects with newly diagnosed AF from SCREAM (Stockholm CREAtinine Measurements), a healthcare utilization cohort of Stockholm residents, were included. Predictive performance of the AFI, CHADS2, Modified CHADS2, CHA2DS2-VASc, ATRIA, and GARFIELD-AF risk scores was evaluated across three strata of kidney function: normal kidney function [estimated glomerular filtration rate (eGFR) >60 mL/min/1.73 m2], mild CKD (eGFR 30-60 mL/min/1.73 m2), and advanced CKD (eGFR <30 mL/min/1.73 m2). Predictive performance was assessed by discrimination and calibration. During 1.9 years, 3069 (8.5%) patients suffered an IS. Discrimination was dependent on eGFR: the median c-statistic in normal eGFR was 0.75 (range 0.68-0.78), but decreased to 0.68 (0.58-0.73) and 0.68 (0.55-0.74) for mild and advanced CKD, respectively. Calibration was reasonable and largely independent of eGFR. The Modified CHADS2 score showed good performance across kidney function strata, both for discrimination [c-statistic: 0.78 (95% confidence interval 0.77-0.79), 0.73 (0.71-0.74) and 0.74 (0.69-0.79), respectively] and calibration. CONCLUSION: In the most clinically relevant stages of CKD, predictive performance of the majority of risk scores was poor, increasing the risk of misclassification and thus of over- or undertreatment. The Modified CHADS2 score performed good and consistently across all kidney function strata, and should therefore be preferred for risk estimation in AF patients.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. de Jong Y, Fu EL, van Diepen M, et al. Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function. Eur Heart J. 2021. PMID: 33769473. doi:10.1093/eurheartj/ehab059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。